Key result
Rotational atherectomy followed by cutting balloon before DES implantation resulted in a similar risk of MACE compared to plain balloon (OR 0.74; 95% CI 0.25-2.18).
Why the study?
Outcomes of rotational atherectomy and cutting balloon versus plain balloon before drug-eluting stent implantation in calcified coronary lesions needed comparison.
Does rotational atherectomy followed by cutting balloon reduce MACE compared to plain balloon before DES implantation in patients with calcified coronary lesions?
Meta-Analysis (n=315)
Does rotational atherectomy followed by cutting balloon reduce MACE compared to plain balloon before DES implantation in patients with calcified coronary lesions?
Odds Ratio: 0.74 (95% CI 0.25–2.18)
In patients with calcified coronary lesions, using a cutting balloon rather than a plain balloon after rotational atherectomy before DES implantation reduces target lesion revascularization without affecting overall MACE.
Supports RACB consideration to potentially lower TLR in calcified lesions; leaves open need for larger RCTs to confirm net clinical benefit.
OBJECTIVE: The aim of this study is to compare outcomes of rotational atherectomy and cutting balloon (RACB) versus rotational atherectomy and plain balloon (RAPB) before drug-eluting stent (DES) implantation in calcified coronary lesions. METHODS: Randomized controlled trials (RCT) and observational studies comparing RACB with RAPB were identified through a systematic search of published literature across multiple databases. Random effect meta-analysis was performed to compare the outcome between the two groups. RESULTS: Four studies were included in the meta-analysis (three observational and one RCT) involving a total of 315 patients. 166 patients had RACB, and 149 patients had RAPB before DES placement with a median follow-up of 11.5 months. Compared with patients who had RAPB there was no difference in MACE (composite of death, myocardial infarction, and target vessel revascularization) (odds ratio [OR]: 0.74; 95% confidence interval [CI]: 0.25-2.18], slow flow/no reflow (OR: 0.71; 95% CI: 0.23-2.16), all-cause mortality (OR: 2.02; 95% CI: 0.28-14.60), and device success rate (OR: 1.79; 95% CI: 0.28-11.18) in the RACB approach. There was a benefit towards less target lesion revascularization in the RACB group; however, this outcome was reported in two studies (OR: 0.29; 95% CI: 0.08-0.99). On meta-regression there was no association between age, sex, diabetes, or lesion location with MACE and all-cause mortality. The studies were homogenous across all outcomes. CONCLUSION: RACB, as compared with RAPB, had a similar risk of MACE, all-cause mortality, device success, and complication, but a lower risk of target lesion revascularization.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2022) conducted a meta-analysis in calcified coronary lesions (n=315). Rotational atherectomy and cutting balloon (RACB) vs. Rotational atherectomy and plain balloon (RAPB) was evaluated on MACE (composite of death, myocardial infarction, and target vessel revascularization) (OR 0.74, 95% CI 0.25-2.18). Rotational atherectomy followed by cutting balloon before DES implantation resulted in a similar risk of MACE compared to plain balloon (OR 0.74; 95% CI 0.25-2.18).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: